Recruiting NA INTERVENTIONAL 2-arm NCT05378334

Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients

Efficacy and Safety of Bone-protecting and Mass-dispersesing Decoction (HuGuXiaoJiTang, HGXJT) Combining With ICIs in Bone Metastatic NSCLC Patients

Sponsor: Guangzhou University of Traditional Chinese Medicine

Conditions Non-small Cell Lung Cancer

Interventions Bone-protecting and Mass-dispersesing Decoction Chemotherapy ICI Placebo

Updated 6 times since 2022 Last updated: Mar 7, 2026 Started: Jun 15, 2022 Primary completion: Sep 1, 2027 Completion: Jan 1, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Non-small Cell Lung Cancer and is currently actively recruiting participants. Guangzhou University of Traditional Chinese Medicine leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Mar 2026 — Present [monthly]

Recruiting NA

Status: Unknown → Recruiting
Apr 2025 — Mar 2026 [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Apr 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Sep 2022 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Jun 2022 — Sep 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guangzhou University of Traditional Chinese Medicine

Data source: Guangzhou University of Traditional Chinese Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China